Turkey / Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment for Turkish Pharma
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
Address: Yenişehir Mah. Özgür Sokak 16, Ataşehir/ Istanbul,Turkey
Tel: 0216 456 65 70
Web: http://www.berkoilac.com.tr/default.aspx
BERKO PHARMACEUTICALS initiallystarted its operations under the name of BERAN LABORATORY in Diyarbakır.A few years later, in 1984, BERKO PHARMACEUTICALS was founded inIstanbul. BERKO PHARMACEUTICALS, which initially produced a galenicpreparation, soon started to manufacture therapeutic medicines in itsown production facility.
In the early 2000’s, BERKOPHARMACEUTICALS started licensing new pharmaceuticals needed in Turkey.Consequently, various forms of zinc-containing ZINCO-branded productswere offered for the benefit of Turkish Medicine. Around that time, anagency agreement was signed with the Italian GANASSINI company, andsubsequently the importation and distribution of the Ear-Nose-Throatspecific medicines, TONIMER line, were initiated.
BERKOPHARMACEUTICALS founded its own production facilities early in 2004,and has come to produce a wide product range of ground breakingmedicine, all of which, with the exceptions of a few imports, itproduces itself in its own modern production facilities. BERKOPHARMACEUTICALS continues to offer both new and existing high-demandedbrands to the pediatric market.
BERKO PHARMACEUTICALS’ new high-tech facility started production in 2009.
BERKOPHARMACEUTICALS’ new production facility in Sultanbeyli, Istanbul, isdesigned to produce licensed medicines under the supervision of theMinistry of Health, Republic of Turkey. The 5000 m2 indoor facility wasdesigned in accordance with all relevant GMP requirements. Both thebuilding and the inner equipment -machine park and laboratory- of thisfactory were constructed by the latest technology.
Our liquidmanufacturing capacity under normal working conditions is 6,500,000boxes per year for syrups; 6,500,000 boxes per year for drops; and8,000,000 boxes per year for solid medicines.
BERKO PHARMACEUTICALS aims to manufacture only products that will always be in demand, while continuing to break new grounds.
Aftasol solution
Berko-Fiz Nasal Drops
ACD3 drops
Alores Syrup
Caillou Fish
Dencol Gel Spray
FerroZinc Syrup
Folas Drop…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech…
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the…
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare…
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on…
Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the…
Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has…
Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city…
Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing,…
Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish…
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish…